The initiation of eukaryotic DNA replication is regulated by three protein kinase classes: cyclin-dependent kinases (CDK), Dbf4dependent kinase (DDK) and the DNA damage checkpoint kinases 1 . CDK phosphorylation of two key initiation factors, Sld2 and Sld3, promotes essential interactions with Dpb11 (refs 2-4), whereas DDK acts by phosphorylating subunits of the Mcm2-7 helicase 5 . CDK has an additional role in replication by preventing the re-loading of Mcm2-7 during the S, G2 and M phases 6 , thus preventing origin re-firing and re-replication. During the G1 phase, both CDK and DDK are downregulated, which allows origin licensing and prevents premature replication initiation 3 . Origin firing is also inhibited during the S phase when DNA damage or replication fork stalling activates the checkpoint kinases 7-10 . Here we show that, analogous to the situation in the G1 phase, the Saccharomyces cerevisiae checkpoint kinase Rad53 inhibits both CDK-and DDK-dependent pathways, which acts redundantly to block further origin firing. Rad53 acts on DDK directly by phosphorylating Dbf4, whereas the CDK pathway is blocked by Rad53mediated phosphorylation of the downstream CDK substrate, Sld3. This allows CDK to remain active during the S phase in the presence of DNA damage, which is crucial to prevent re-loading of Mcm2-7 onto origins that have already fired 6 . Our results explain how checkpoints regulate origin firing and demonstrate that the slowing of S phase by the 'intra-S checkpoint' is primarily due to the inhibition of origin firing.
The initiation of eukaryotic DNA replication is regulated by three protein kinase classes: cyclin-dependent kinases (CDK), Dbf4dependent kinase (DDK) and the DNA damage checkpoint kinases 1 . CDK phosphorylation of two key initiation factors, Sld2 and Sld3, promotes essential interactions with Dpb11 (refs 2-4), whereas DDK acts by phosphorylating subunits of the Mcm2-7 helicase 5 . CDK has an additional role in replication by preventing the re-loading of Mcm2-7 during the S, G2 and M phases 6 , thus preventing origin re-firing and re-replication. During the G1 phase, both CDK and DDK are downregulated, which allows origin licensing and prevents premature replication initiation 3 . Origin firing is also inhibited during the S phase when DNA damage or replication fork stalling activates the checkpoint kinases [7] [8] [9] [10] . Here we show that, analogous to the situation in the G1 phase, the Saccharomyces cerevisiae checkpoint kinase Rad53 inhibits both CDK-and DDK-dependent pathways, which acts redundantly to block further origin firing. Rad53 acts on DDK directly by phosphorylating Dbf4, whereas the CDK pathway is blocked by Rad53mediated phosphorylation of the downstream CDK substrate, Sld3. This allows CDK to remain active during the S phase in the presence of DNA damage, which is crucial to prevent re-loading of Mcm2-7 onto origins that have already fired 6 . Our results explain how checkpoints regulate origin firing and demonstrate that the slowing of S phase by the 'intra-S checkpoint' is primarily due to the inhibition of origin firing.
Activation of the DNA damage checkpoint kinases in the S phase regulates genomic replication in at least two ways: first by protecting stalled replication forks [11] [12] [13] [14] and second by blocking further origin firing [7] [8] [9] [10] . To determine whether the DNA replication machinery is directly regulated by checkpoints, we set out to identify Rad53 substrates in vivo in the budding yeast, Saccharomyces cerevisiae. A library of tagged replication proteins was screened for Rad53-dependent reduction in mobility in SDS-polyacrylamide gel electrophoresis (PAGE) after treatment with the ribonucleotide reductase inhibitor hydroxyurea ( Supplementary Table 1 ). Two essential replication factors exhibited a hydroxyurea-and Rad53-dependent shift in mobility ( Fig. 1a, b ): Dbf4, a previously characterized Rad53 substrate 15 , and Sld3 (refs 2, 3). Phosphatase treatment of Sld3 purified from hydroxyurea-treated yeast cells converted the slower migrating bands into a single, faster migrating band ( Fig. 1b) , indicating that Sld3 is phosphorylated in a hydroxyurea-and Rad53-dependent manner. The phosphorylation-dependent shift of Sld3 also occurred in cells entering the S phase in the presence of the DNA alkylating agent methyl methanesulphonate (MMS), but did not occur during unperturbed S phase ( Supplementary Fig. 1a ), and not require Dun1 ( Supplementary  Fig. 1a ), a checkpoint kinase downstream of Rad53. These data indicate that, like Dbf4, Sld3 is a target of Rad53 in vivo.
The magnitude of the shift and the multitude of bands seen in SDS-PAGE ( Fig. 1b ) indicated that the serine/threonine-rich Sld3 protein ( Fig. 1c ) is multiply phosphorylated after checkpoint activation. We used purified Rad53 to phosphorylate a series of Sld3 fragments ( Fig.   1c ) in vitro. Figure 1d and Supplementary Fig. 1b show that Rad53 predominately phosphorylates Sld3 in two carboxy-terminal fragments. To compare this to phosphorylation in vivo, we expressed and purified a version of Sld3 in which the N-and C-terminal domains were tagged and could be separated by cleavage with TEV protease (Fig. 1c, top) . Figure 1e shows that only the C-terminal domain of Sld3 exhibited a l phosphatase-sensitive shift in SDS-PAGE after hydroxyurea treatment in vivo. To identify individual Rad53 sites in Sld3 in vitro we phosphorylated arrays of peptides corresponding to the entire Sld3 amino acid sequence attached to a cellulose membrane. Consistent with Fig. 1d , most of the phosphorylated peptides occurred within the C-terminal domain of Sld3 ( Supplementary Fig. 1c ). Because of the extensive overlap in the peptides on the array (Supplementary Fig. 2a-d ) most sites could be identified unambiguously. All 38 potential serine and threonine phosphorylation sites were mutated to alanine ( Fig. 1c and Supplementary Table 2 ). Compared to the wild-type protein, this allele of Sld3 (sld3-A) shifted only slightly in SDS-PAGE after hydroxyurea treatment ( Fig. 1f ). A variety of sld3 mutants containing subsets of the 38 sites mutated to alanine all show reduced phosphorylation shift, indicating that many or most of the sites contribute to the full phosphorylation shift and Sld3 inhibition in vivo ( Supplementary Fig. 2e , f). The residual shift in sld3-A may be due to additional sites missed in our analysis or to cryptic sites only phosphorylated when the stronger sites in the wild-type protein are absent. Yeast strains expressing sld3-A as the sole copy of Sld3 showed no increased sensitivity to hydroxyurea or DNA damaging agents and did not exhibit synthetic growth defects with several conditional alleles of essential replication proteins ( Supplementary Fig. 3 ), indicating that the Sld3-A protein is functional for DNA replication.
These Rad53 sites are primarily in the C-terminal portion of Sld3, where the essential CDK sites (Thr 600, Ser 622) are found ( Fig. 1c ). Figure 2a shows that, whereas CDK phosphorylation of the C terminus of Sld3 in vitro allows direct binding to Dpb11 but not to a Dpb11 truncation lacking the first BRCT repeat (DN), subsequent Rad53 phosphorylation of Sld3 inhibits interaction with Dpb11. Mutation of the most efficiently phosphorylated Rad53 sites in the C terminus of Sld3 to aspartate residues (sld3-12D; Fig. 1c and Supplementary  Table 2 ), to mimic constitutive phosphorylation, also blocks interaction with Dpb11 in vitro ( Fig. 2b ) without blocking CDK phosphorylation ( Supplementary Fig. 4 ) and is unable to support growth in vivo (Fig. 2c ). The CDK-dependent interaction between Sld3 and Dpb11 can be bypassed in vivo by direct covalent fusion of these proteins 3 . Figure 2c shows that fusion of the Sld3-12D mutant protein to Dpb11 restored its ability to support growth. This indicates that Sld3 phosphorylation by Rad53 inhibits its ability to interact with Dpb11 in vitro and in vivo. Two additional Rad53 phosphorylation sites (Ser 306, Ser 310) that contribute to the Rad53 phosphorylation-dependent shift of Sld3 in SDS-PAGE ( Supplementary Fig. 2e ) lie considerably farther upstream of the Dpb11 interaction domain. Mutation of these two sites to aspartate in the sld3-12D background also produced a protein (Sld3-14D; Fig. 1c ) that could not interact with Dpb11 ( Fig. 2b ) and could not support growth (Fig. 2c) . In contrast to sld3-12D, however, sld3-14D could not support growth after fusion to Dpb11 (Fig. 2c) . Previous work has shown that Sld3 also interacts with Cdc45 and the GINS subunit Psf1 in a two-hybrid assay 16 . A mutant protein in which Ser 306 and Ser 310 were changed to aspartate (Sld3-2D) interacted with both Dpb11 and Psf1 in a two-hybrid assay (Fig. 2d ). However, compared to wild type, Sld3-2D showed a reduced interaction with Cdc45. Consistent with this weakened interaction, overexpression of Cdc45 allowed the Sld3-14D-Dpb11 fusion to support growth ( Fig.  2e ). These results indicate that Sld3 phosphorylation by Rad53 inhibits interactions with both Dpb11 and Cdc45. A mutant of Sld3 in which 34 Rad53 sites were converted to aspartate (sld3-34D; Fig. 1c ) did not support growth, even when fused to Dpb11 (Fig. 2c ) in the presence of overexpressed Cdc45 (data not shown). This suggests that additional functions of Sld3 may be inhibited in the fully phosphorylated molecule.
Because Sld3 is essential for replication initiation but not elongation 17 and interactions with Cdc45 and Dpb11 are essential for its function, we hypothesized that phosphorylation of Sld3 by Rad53 may act to prevent late origin firing. Mutation of these sites to alanine might, therefore, bypass the ability of Rad53 to block late origin firing. Lanes 1-4 of Fig. 3a (bottom panel) show that the sld3-A allele by itself was not sufficient to allow accumulation of replication intermediates from the late origin ARS501 in hydroxyurea. Because Dbf4 is also a substrate of Rad53 ( Fig. 1a ), we next tested the possibility that Rad53 inhibits both Sld3 and Dbf4. We combined the sld3-A allele with the mcm5-bob1 mutant, which bypasses the requirement for Cdc7-Dbf4 in vivo 18 . Similar to sld3-A, the mcm5-bob1 mutant by itself did not allow firing of ARS501 in hydroxyurea (Fig. 3a , lanes 5-8). However, Fig. 3a shows that the combination of sld3-A with mcm5-bob1 allowed ARS501 firing in hydroxyurea ( Fig. 3a, lanes 9-12) . The timing and extent of Rad53 activation as judged by its hyperphosphorylation was Input 10% LETTER RESEARCH similar in these strains (Fig. 3b ), indicating that late origin firing in the double mutant is not due to a defect in checkpoint activation. Indeed, the extent of Rad53 phosphorylation seems greater in the double mutant, consistent with an increased number of origins being fired and, hence, an increased number of stalled replication forks (ref. 19 ; see also Fig. 3d and Supplementary Figs 6 and 7) . We used the peptide array approach described above to identify 19 Rad53 phosphorylation sites in Dbf4 ( Supplementary Fig. 5a and Supplementary Table 3 ). Mutation of all these sites to alanine (dbf4-19A) significantly reduced the shift of Dbf4 in hydroxyurea ( Fig. 3c ). Combination of dbf4-19A with sld3-A resulted in the activation of several late origins in hydroxyurea as shown by the accumulation of replication intermediates both by 1D electrophoresis (Fig. 3d and Supplementary  Fig. 5b , c) and 2D electrophoresis (Fig. 3e) . Rad53 activation was similar in the single and double mutant strains (Fig. 3d, lower panel) .
Strains expressing dbf4-19A, however, were unable to grow at 37 uC ( Supplementary Fig. 6a ). We used two approaches to exclude the possibility that the deregulation of late origin firing was linked to this temperature sensitivity. First, we identified four serine residues in Dbf4 which, when changed to alanine, generated a mutant (dbf4-4A) that allowed origin firing in hydroxyurea when combined with sld3-A but was no longer temperature sensitive ( Supplementary Fig. 6b ). Second, we reasoned that if deregulation of late origin firing was linked to loss of Dbf4 function, then both temperature sensitivity and late origin firing should be recessive; however, if dbf4-19A contributes to late origin firing in hydroxyurea because it is refractory to Rad53 inhibition, it should be dominant. We introduced the sld3-A and dbf4-19A alleles as second copies into cells containing wild-type DBF4 and SLD3. This strain is no longer temperature sensitive ( Supplementary  Fig. 6b ), and the late origin ARS501 fires in hydroxyurea (Fig. 3f) . Therefore, deregulation of late origin firing in hydroxyurea is not due to a recessive defect in the SLD3/DBF4 alanine mutants. This also indicates that Rad53 must inhibit the entire cellular pools of Sld3 and Dbf4 to block origin firing completely, which is consistent with the fact that the entire population of both Sld3 and Dbf4 appears to be phosphorylated in hydroxyurea (Figs 1b and 3c ). Taken together, these results show that Rad53 prevents origin firing redundantly by phosphorylating both Sld3 and Dbf4. As is the case for both rad53D and mrc1D cells 8, 20, 21 , the order of origin firing in the dbf4-19A sld3-A double mutant appears unaffected because the late origins ARS501, ARS603 and ARS1412 fire after the early origins, ARS305, ARS607 and ARS315, in hydroxyurea ( Fig. 3d and Supplementary Fig. 5b) , indicating that the temporal order of origin firing may remain intact.
In contrast to wild-type cells, rad53 mutant cells traverse the S phase quickly in the presence of MMS 22 , at least partly because of global derepression of origin firing 11 . This 'intra-S checkpoint' is lost in the dbf4-4A sld3-A double mutant because its S phase in MMS is at least as fast as that of the rad53D sml1D strain. Rad53 activation occurred normally in the dbf4-4A sld3-A double mutant (Fig. 4b) . Therefore, origin firing seems to be globally derepressed in this double mutant. The dbf4-4A sld3-A double mutant actually traverses the S phase slightly faster than the rad53 mutant in MMS. Rad53 is also required to stabilize forks that have stalled [11] [12] [13] [14] 19 . rad53 mutants do not resume DNA synthesis efficiently after a hydroxyurea arrest; however, the dbf4-4A sld3-A double mutant is capable of resuming replication with similar kinetics to the wild-type strain ( Supplementary Fig. 7a ). Consistent with this, the dbf4-4A sld3-A double mutant retained high viability during this rapid S phase in the presence of MMS (Fig. 4c) as well as in the presence of high concentrations of hydroxyurea ( Supplementary Fig. 7b ). Under both conditions the rad53 mutant lost viability. This provides additional evidence that the primary role of Rad53 in maintaining cell viability after DNA damage correlates with the protection of replication forks. The checkpoint-dependent block to late origin firing seems to make only a minor contribution to cell 
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viability after genotoxic stress. It will be interesting to determine whether it contributes quantitatively to genome stability.
Checkpoint-dependent inhibition of origin firing is a conserved feature of eukaryotic DNA replication. Here we have shown that the checkpoint inhibits origin firing in budding yeast by interfering with both the CDK-and DDK-dependent activation of origins: by phosphorylation of Sld3, which prevents interaction with Cdc45 and Dpb11, and by phosphorylation of Dbf4. How DDK is inhibited by Dbf4 phosphorylation is presently unclear. Inhibition of late origin firing by Rad53 is analogous to the inhibition of replication during the G1 phase ( Fig. 4d ) when initiation is prevented by the inhibition of both CDK and DDK. CDK cannot be inhibited during the S phase in budding yeast because it is required to prevent the re-licensing of earlyfiring origins 6 . In metazoans, the DNA replication checkpoint may inhibit CDK activity, for example through phosphorylation and degradation of the Cdc25 phosphatases 23 , as there are CDK-independent pathways that also prevent re-licensing, such as geminin 6 and PCNAdependent Cdt1 degradation 24 . However, Cdc25 degradation is unlikely to represent the sole mechanism by which origin firing is inhibited in mammalian cells 25, 26 . It is likely that the checkpoint in metazoans also targets replication initiation factors directly and Dbf4 has been shown to be a checkpoint substrate in other organisms 15 . An orthologue of Sld3 called Treslin and TICRR has recently been identified in metazoans [27] [28] [29] , and it will be interesting to see if it is also a target of checkpoint kinases. With the identification of these key Rad53 substrates in yeast, together with recent work identifying the key CDK and DDK substrates, we now have a detailed understanding of how protein kinases regulate the initiation of DNA replication.
METHODS SUMMARY
Yeast strains and methods. All yeast strains were based on W303-1a (MATa ade2-1 ura3-1 his3-11,15 trp1-1 leu2-3,112 can1-100) and are described in Supplementary Information. Mutagenesis of Sld3 at the endogenous locus was done as described 3 . Cell growth and cell cycle blocks, samples for flow-cytometric analysis and yeast protein extracts were collected and processed as described previously 3 . Kinase assays and peptide arrays. Recombinant Rad53 was purified from Escherichia coli and assayed in vitro as previously described 30 . Peptide arrays were synthesized directly onto cellulose membranes using an Intavis Autospot. Detection of replication intermediates. 1D and 2D gels were performed as previously described with minor modifications (see Supplementary Methods) 
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